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CORONARY ARTERY 
BYPASS WITHOUT 
CARDIOPULMONARY 
BYPASS: ANALYSIS OF 
SHORT-TERM AND 
MID-TERM OUTCOME 
IN 220 PATIENTS 
Two hundred twenty patients, preferentially those with high-risk condi- 
tions, underwent coronary artery bypass grafting without cardiopuimonary 
bypass. Early unfavorable outcome vents included operative mortality (7 
patients, 3.2%), nonfatal perioperative myocardial infarction (6 patients, 
2.7%), cerebrovascular accident (1 patient, 0.4%), and sternal infection (3 
patients, 1.4%). There were two deaths (13%) among 15 patients with 
calcified aorta and four (12%) in 33 patients who underwent emergency 
operation. Multivariate analysis revealed these two risk factors to be the 
only predictors of early mortality (odds ratios, 8.0 and 9.8, respectively). 
Preoperative risk factors such as left ventricular dysfunction (ejection 
fraction <_35%) (40 patients, 18%), congestive heart failure (46 patients, 
21%), acute myocardial infarction (59 patients, 27%), cardiogenic shock (7 
patients, 3%), age 70 years or older (59 patients, 27%), renal failure (19 
patients, 9%), and cerebrovascular ccident and carotid disease (11 pa- 
tients, 5%) were not found to be major predictors of early mortality or 
unfavorable outcome. During 12 months of follow-up (range 1 to 21 
months), there were four cardiac and three noncardiac deaths (1-year 
actuarial survival 93%) and 17 cases (7.7%) of early return of angina. 
Calcified aorta, nonuse of the internal mammary artery, reoperation, and 
diabetes mellitus were independent predictors of unfavorable vents. We 
conclude that coronary artery bypass grafting without cardiopulmonary 
bypass can be done with relatively low operative mortality, although there 
seems to be an increased risk for early return of angina. This procedure 
should therefore be considered for patients with appropriate coronary 
anatomy, in whom cardiopulmonary bypass poses a high risk. This 
procedure is still hazardous with calcified aorta or emergency operation. 
(J THORAC CARDIOVASC SURG 1995;110:979-87) 
Yaron Moshkovitz, MD, ~ Ayala Lusky, MSc, b and Rephael Mohr, MD, 
Tel Hashomer, Israel 
T he first operation for coronary artery disease in which the internal mammary artery (IMA) was 
anastomosed on a beating heart to the left anterior 
descending artery (LAD) was done by Kolesov and 
Potashov 1 in Leningrad in 1964. Favorable results with 
the use of cardiopulmonary b pass (CPB) for saphe- 
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nous vein 2' 3 and IMA 4 coronary artery bypass grafting 
(CABG) have made CABG with CPB the surgical 
procedure of choice for ischemic heart disease. 
Although current methods of CPB are remarkably 
safe, there is incontrovertible evidence that various 
damaging effects of CPB do occur. 5 Although in the 
majority of patients the adverse effects of CPB are 
minor and reversible, patients with significant func- 
tional impairment of various organ systems may not 
tolerate the added deleterious effects of CPB, which 
may be irreversible and even fatal. 
During the 1980s and the beginning of the 1990s, 
several series of CABG operations without CPB 
were reported. 6-1° Although some of these series 
were relatively large, they were neither specifically 
based on patients with high-risk conditions, nor did 
they try to identify risk factors for unfavorable 
outcome after the procedure. 
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Table I. Univariate analysis fo r  early mortal i ty  and  total  unfavorab le  outcome events 
Prevalence Early mortality Total unfavorable vents 
Risk factor n %* n 1 %? n z %¢ p Vahte n I %? n e %¢ p Value 
Age ->70 yr 59 27 4 6.8 3 1.8 NS 10 17 30 19 NS 
Female gender 45 20 2 4.4 5 2.8 NS 9 20 31 18 NS 
Left main coronary 25 11 2 8.0 5 2.5 NS 9 36 31 16 0.01 
artery stenosis 
Angina class 4 99 45 7 7.0 0 0 <0.01 23 23 17 14 0.08 
Acute MI (<24 hr) 19 9 1 5.2 6 3.0 NS 3 16 37 18 NS 
Recent MI (<2 wk) 40 18 2 5.3 5 2.9 NS 7 17 33 18 NS 
Complicated PTCA 10 4 0 0 7 3.3 NS 0 0 40 19 NS 
EF -<35% 40 18 1 2.5 6 3.3 NS 7 18 33 18 NS 
Congestive heart failure 46 21 1 2.2 6 3.4 NS 6 13 34 20 NS 
Cardiogenic shock 7 3 0 0 7 3.3 NS 1 I4 39 18 NS 
Diabetes mellitus 48 22 2 4.2 5 2.9 NS 13 27 27 16 0.07 
Hypertension 89 40 0 0 7 5.3 NS 14 16 26 20 NS 
CVA/carotid disease 11 5 1 9.0 6 2.8 NS 1 9 39 19 NS 
Aortoiliac disease 33 15 1 3.0 6 3.3 NS 7 21 33 18 NS 
Calcified aorta 15 7 2 13.3 5 2.5 0.07 7 47 33 16 <0.01 
Chronic renal failure 19 9 0 0 7 3.5 NS 1 5 39 19 NS 
Severe COPD 12 5 1 8.3 6 2.8 NS 4 33 36 17 NS 
Emergency operation 33 15 4 12.2 3 2.1 0.06 8 24 32 17 NS 
Repeat CABG 30 14 1 3.3 6 3.1 NS 9 30 31 16 0.07 
Nonuse of IMA 29 13 2 6.9 5 2.6 NS 9 31 31 16 0.05 
Single graft 78 35 1 1.3 6 4.2 NS 17 22 23 16 NS 
Cx marginal graft 49 22 3 6.1 4 2.3 NS 11 22 29 17 NS 
n, Number of patients with this risk factor; n1, number of deaths in patients with this risk factor; nz number of deaths in patients without this risk factor; NS, 
not significant; PTCA, percutaneous transluminal coronary angioplasty; EF, ejection fraction; CVA, cerebrovascular accident; COPD, chronic obstructive 
pulmonary disease; Cx, circumflex. 
*Percent evaluated for the entire study group. 
?Percent of nj out of n. 
:~Percent ofn 2 out of 220 - n. 
As  more  and more  pat ients  with high-r isk condi -  
t ions are re fe r red  for CABG,  11 we have used the 
approach  of  CABG wi thout  CPB,  on  the basis o f  the 
assumpt ion  that  some pat ients  with high-r isk condi -  
t ions may benef i t  f rom CABG wi thout  CPB.  lz 
Hence  the purpose  o f  this study was to eva luate  
results of  CABG wi thout  CPB in a group composed  
main ly  of  pat ients  with high-r isk cond i t ions  to iden- 
tify independent  risk factors for  CABG wi thout  CPB 
and to suggest possible advantages  and d isadvan-  
tages of  this procedure .  
Patients and methods 
Patient population. Between December  1991 and 
September 1993, 220 patients underwent CABG with- 
out CPB. One of us (R.M.) per formed all operations. 
This group comprises 22% of 990 isolated CABG 
operations done overall in our institution during that 
period. There were 175 male (80%) and 45 female 
(20%) patients. Patients' ages ranged from 40 to 82 
years (mean 63 years). The decision to perform CABG 
without CPB was primarily based on the following 
considerations: (1) the potential  relative benefit from 
avoiding CPB, because it was assumed that the higher 
the risk for CABG with CPB, the greater the patients'  
relative benefit from avoiding CPB, and (2) the feasi- 
bility of the procedure,  which was determined by the 
size and accessibility to the diseased coronary vessels as 
demonstrated on the coronary angiogram. The smaller 
the size of the coronary vessels to be bypassed, or the 
more distal their position in the circumflex arterial 
system, the less feasible the procedure.  Coronary ves- 
sels with a diameter of less than 1.5 mm or calcified or 
intramyocardial  vessels were regarded as contraindica- 
tions for this procedure. We also favored use of the 
standard operative technique in cases that needed four 
or more grafts. 
When there was greater potential benefit from avoiding 
CPB, a lesser degree of feasibility was accepted. The 
patient population risk profile is shown in Table I. The 
mean number of risk factors listed in Table I was 3.7 per 
patient (Table II). 
Surgical technique. Patients were operated on through 
a midline sternotomy, except for six patients in whom a 
left thoracotomy was preferred (four reoperations and 
two primary operations for revascularization of the cir- 
cumflex and LAD systems only. Before the IMA was 
freed, heparin was administered in a dose of 2 mg/kg 
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Table I I .  Distribution o f  risk factors 
No. o frisks n % 
0 2 1 
1 31 14 
2 36 16 
3 39 18 
4 41 19 
5 34 15 
6-10 37 17 
Total 220 100 
Nonuse of IMA, single graft, and circumflex artery marginal graft were not 
included as risk factors in this table. 
weight o keep the activated clotting time greater than 400 
seconds. 
Exposure and fixation of the anastomotic site were 
achieved with superficial (4-0 silk) sutures and deep (3-0 
Ti-Cron polyester fiber, Davis & Geck, Danbury, Conn.) 
sutures, application of hemostatic tourniquets (polytet- 
rafluoroethylene* or 5-0 Prolene polypropylene, Ethicon, 
Inc., Somerville, N.J.), and spurts of air to obtain a 
bloodless field. Because of previous reports of hemostatic 
suture-related coronary stenotic lesions, 13 distal hemo- 
static sutures were used only when essential. The hemo- 
static sutures were tightened just after arteriotomy to 
shorten the regional ischemic time. 
Distal anastomoses were done with continuous 7-0 
Prolene sutures and proximal anastomoses with 5-0 Pro- 
lene sutures with a partial occluding clamp. In the major- 
ity of patients with calcified aorta it was possible to 
palpate a skip area on the ascending aorta that could serve 
as a site for one proximal vein graft anastomosis, on the 
cupula of which other proximal anastomoses were con- 
structed. For better detection of skip areas, blood pres- 
sure was temporarily reduced by partial inflow occlusion 
with a cotton tape snare around the inferior vena cava. 
Exposure of marginal branches of the circumflex coro- 
nary artery was achieved by gentle, gradual rotation of the 
heart. Hemodynamic nstability, which primarily occurred 
during exposure of the marginal branches of the circum- 
flex coronary artery, was managed by rapid fluid adminis- 
tration, use of dobutamine, infusion of glucose-insulin 
solution, or preoperative insertion of an intraaortic bal- 
loon pump. In cases that necessitated significant rotation 
of the heart to reach a marginal branch of the circumflex 
artery, revascularization f other territories was anteced- 
ently done. Body hypothermia was avoided by adjustment 
of operating room temperature, placement of the patient 
on a warming mattress, and infusion of warm solutions. 
Operative data (Table III). Because 35% of the pa- 
tients in this study received a single graft, the mean 
number of grafts per patient was 1.9. Only 22% of patients 
received a graft to a marginal branch of the circumflex 
artery. This relatively low percentage stems from the fact 
that a high proportion of patients in whom a marginal 
graft was critical were preselected to be operated on with 
CPB. Ischemic time for grafting either the LAD or the 
Table I I I .  Operative data 
Variable n % 
Single graft 78 35 
Two grafts 96 44 
Three grafts 39 18 
Four grafts 6 3 
Five grafts 1 0.5 
Cx marginal graft 49 22 
Use of IMA 191 87 
Sequential LIMA 5 2.3 
Use of RIMA 10 4.5 
n, Number of patients; Cx, circumflex artery; LIMA, left IMA; R/MA, right 
IMA. 
right coronary artery was 8 -+ 4 minutes (mean ~ SD*) 
and for the marginal branches of the circumflex artery 13 
-+ 7 minutes (mean -+ SD). Hospital stay was 6.1 _+ 3.2 
days (mean _+ SD). 
Statistical analysis. Postoperative survival is expressed 
by the Kaplan-Meier method, and survival curves were 
compared by Breslow statistics. The X 2 test was used to 
compare discrete (categoric) variables, and the t test was 
used to compare continuous variables. Data are expressed 
as mean plus or minus the standard eviation, and statis- 
tical significance was accepted at p < 0.05. 
To predict perioperative mortality and unfavorable 
outcome vents by various risk factors, logistic regression 
analysis was used. Odds ratio (OR) and 95% confidence 
intervals (CI) were evaluated. 14Because one of the aims 
was to evaluate the association between each risk factor 
and survival time (controlling for other risk factors), Cox's 
proportional hazard model was used. 15 All analyses were 
done by BMDP software (BMDP Statistical Software, 
Inc., Los Angeles, Calif.), version 1990. 
Results 
Ear ly  unfavorable outcome events (Table IV).  
Seven pat ients (3.2%) died per ioperat ive ly  (during 
hospital izat ion or within 30 days after the opera-  
tion), all of  per ioperat ive myocardia l  infarct ion 
(MI).  Another  six pat ients (2.7%) had per ioperat ive 
nonfatal  MI,  one of whom underwent  salvage reop-  
erat ion without CPB. The other  case of early reop-  
erat ion was a result of compl icated percutaneous 
transluminal  coronary ngioplasty of  the LAD prox- 
imal to a stenosed IMA anastomosis.  
Analysis of the causes of  both fatal and nonfatal  
cases of per ioperat ive MI  showed nine (4.1%) were 
caused by acute graft occlusion, three (1.4%) by 
incomplete revascularizat ion, and one by thrombo-  
sis of a nonbypassed coronary artery. 
Only one pat ient  (0.4%) had a cerebrovascular  
accident, which occurred on the first postoperat ive 
*Gore-Tex is a registered trademark ofW. L. Gore & Associates, 
Elkton, Md. *Standard eviation. 
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Table IV. Early unfavorable outcome vents 
Event  and cause n % 
Mortality 7 3.2 
Acute graft occlusion 5 
Incomplete revascularization 1 
Thrombosis of native coronary artery 1 
Nonfatal MI 6 2.7 
Acute graft occlusion 4 
Incomplete revaseularizatton 2 
Reoperation 2 0.9 
Acute graft occlusion 1 
Technical error in IMA anastomosis to LAD 1 
Sternal infection 3 1.4 
Cerebrovascular accident 1 0.4 
Postoperative iatrogenic 1 
day as a result of air embolization through the left 
atrial catheter. 
Late unfavorable outcome events (Table V). Late 
follow-up (1 to 21 months after operation, mean 12 
months) was achieved in 92% of patients. The vast 
majority of patients who were lost to follow-up were 
new immigrants with no permanent address. 
During this period, seven patients (3.2%) died. 
Four (1.8%) deaths were cardiac related. Two pa- 
tients (0.9%) had a nonfatal MI, and in 17 patients 
(7.7%) angina returned. Four patients underwent 
reoperation, three because of return of angina and 
one for mitral valve repair. In four patients who had 
a perioperative MI congestive heart failure class 3 to 
4 developed, and one of these patients eventually 
died. At an average follow-up of 1 year, 180 patients 
(82%) had an uneventful outcome and are feeling 
well. 
Analysis of the causes of all late unfavorable 
events showed that 11 (5.0%) were a result of 
incomplete revascularization a d 9 (4.1%) a result 
of graft malfunction. 
Analysis of mortality events. Life-table analysis 
of the entire group showed 93% survival up to 21 
months of follow-up (Fig. 1). Univariate analysis 
(Table I) demonstrated angina class 4 as a signifi- 
cant predictor of early mortality, whereas emer- 
gency operation and calcified aorta fell short of 
statistical significance. However, after adjustment 
for previously identified demographic, linical, and 
surgical predictors of outcome, 16' 17 emergency op- 
eration (OR 9.8, CI 95% 1.9 to 49.9) and calcified 
aorta (OR 8.0, CI 95% 1.2 to 53.5) emerged as 
independent risk factors for early mortality. Analysis 
of both early and late mortality events showed 
diabetes (OR 6.3, CI 95% 1.5 to 27.4) to be an 
independent predictor in addition to calcified aorta 
Table V. Late unfavorable outcome vents 
Event  and cause n % 
Mortality 7 3.2 
Cardiac 4 
Noncardiac (carcinoma, 3 
CVA, renal failure) 
Nonfatal MI 2 0.9 
Incomplete revascularization 2 
Return of angina 17 7.7 
Incomplete revascularization 10 
Stenotic anastomosis of IMA 4 
Distal stenosis 1 
Unknown 2 
Reoperation 4 1.8 
Stenotic anastomosis of IMA 1 
Incomplete revaseularization I 
Distal stenosis 1 
Mitral valve repair 1 
Congestive heart failure 4 1.8 
Nonfatal MI 4 
Events recorded with 92% follow-up for 1 to 21 months, mean 12 months. 
CVA, Cerebrovascular accident. 
(OR 17.1, CI 95% 2.0 to 143.2) and emergency 
operation (OR 6.5, CI 95% 1.1 to 38.8) (Figs. 2 and 
3). 
Analysis of total unfavorable outcome events. 
Univariate analysis of total unfavorable outcome 
events (Table I) demonstrated calcified aorta, left 
main coronary artery disease, and nonuse of the 
IMA to be significant predictors. However, multiva- 
riate analysis did not reveal left main coronary 
artery disease as an independent predictor. The only 
independent risk factors for unfavorable outcome 
were calcified aorta (OR 5.2, CI 95% 1.7 to 16.3), 
nonuse of the IMA (OR 3.3, CI 95% 1.3 to 10.0), 
reoperative CABG (OR 2.8, CI 95% 1.1 to 7.4), and 
diabetes (OR 2.7, CI 95% 1.2 to 6.1). 
Discussion 
Because mortality and morbidity of CABG are 
related among other things to the use of CPB, 
established risk factors for CABG with the use of 
CPB may not necessarily be significant when CPB is 
avoided. An important finding of this study was that 
risk factors such as left ventricular dysfunction, 
congestive heart failure, acute MI, cardiogenic 
shock, complicated percutaneous transluminal cor- 
onary angioplasty, reoperative procedures, renal 
failure, and peripheral vascular disease were not 
associated with increased mortality in patients un- 
dergoing CABG without CPB. Although old age, 
left main coronary artery stenosis, previous cerebro- 
vascular accident or carotid disease, and chronic 
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Fig. 1. Survival curve for entire study group. Standard errors and number of patients at risk across time 
intervals are indicated. 
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Fig. 2. Survival curves by calcified versus noncalcified aorta. Standard errors and number of patients at 
risk across time intervals are indicated. 
obstructive pulmonary disease were also not found 
to be significant risk factors for mortality by univa- 
riate or multivariate analysis, a trend for higher 
mortality could be observed. 
In our opinion, the subgroup of patients who may 
benefit most from CABG without CPB are those 
with left ventricular dysfunction. Operative mortal- 
ity in these patients is undoubtedly higher than that 
in those with normal left ventricular function. 1s-22 
Our results are consistent with those of previous 
studies that reported fewer occurrences of low out- 
put state and low mortality in patients with severely 
impaired ventricles who underwent CABG without 
CPB. 8 Only 1 (2.5%) of 40 patients in this series with 
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Fig. 3. Survival curves by emergency versus nonemergency operation. Standard errors and number of 
patients at risk across time intervals are indicated. 
an ejection fraction lower than 35% (including 7 
with ejection fractions lower than 20%) died. These 
results can be explained by the favorable ffect of 
the beating heart on blood supply to the subendo- 
cardium 23 and the better preservation of interven- 
tricular septal contractility reported after CABG 
without CPB. 6'24 Furthermore, excellent results 
have been reported in patients with left ventricular 
dysfunction when they were operated on with use of 
a support device when CABG was done without 
CPB. 25 An intraaortic balloon pump was inserted 
preoperatively in the present series in 10 patients, 
seven of whom were in cardiogenic shock. None of 
these patients with severely jeopardized myocar- 
dium died (Table I). 
Similar considerations may favor the use of 
CABG without CPB in patients referred for opera- 
tion during acute MI or after complicated percuta- 
neous transluminal coronary angioplasty (sudden 
coronary occlusion during the procedure). The mor- 
tality rate in 59 patients operated on in this series 
during acute MI was 5.2%. None of the 10 patients 
with complicated percutaneous transluminal coro- 
nary angioplasty died (Table I). However, emer- 
gency operation (sometimes associated with an 
acute compromised hemodynamic condition) was 
still found to be a significant independent predictor 
of early mortality. 
Coronary reoperations are associated with rela- 
tively high in-hospital mortality (up to 12% in a 
recently published multicenter Veterans Adminis- 
tration study 22) and morbidity, including periopera- 
tive MI, low cardiac output, and prolonged intuba- 
tion. 22"26'27 Potential disadvantages of the heart 
bypass technique on coronary reoperations include 
inadequate myocardial protection because of diffuse 
coronary disease, the danger of unsuccessful wean- 
ing from CPB because of incomplete revasculariza- 
tion, cardioplegia-induced graft atheroembolism, 
crossclamping of reoperated aorta, and prolonged 
pump runs. All these issues are not relevant when 
one avoids CPB. Indeed, favorable results of reop- 
erative CABG without CPB have been reported. 8'28 
We have done 30 reoperations, four of which were 
done through a left thoracotomy, with one (3.3%) 
early mortality event. Two of the three late mortality 
events in this subgroup were not cardiac related 
(carcinoma of the stomach and cerebrovascular 
accident in a patient with known carotid disease). 
Patients with preoperative renal failure are at 
increased risk for acute renal failure after operation 
because of decreased perfusion, absence of pulsatile 
flow, z9'3° excessive hemolysis, and platelet-fibrin 
microemboli. 3~ Our experience of CABG without 
CPB shows a temporary increase in blood creatinine 
levels in 19 patients (9%) with preoperative renal 
failure (creatinine level 2 to 12 mg/dl). However, 
except for one patient who was receiving long-term 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 4, Part 1 
Moshkovitz, Lusky, Mohr 9 8 5 
dialysis before the operation, none required ialysis 
after the procedure. 
CABG without CPB should address ome of the 
problematic issues of calcified aorta. This study, 
however, found calcified aorta to be an independent 
risk factor of early mortality. There were two mor- 
tality events in the 15 patients with calcified aorta. In 
both, the cause of death was perioperative MI as a 
result of acute thrombosis of a vein graft to the 
LAD. Technical problems with construction of prox- 
imal anastomoses may be the cause of vein graft 
thrombosis. We are currently making every effort to 
avoid manipulation of "untouchable aortas" and 
prefer to use arterial conduits in these patients. 32 
When mortality events in this report are analyzed, 
two observations can be made: first, the most im- 
portant cause of death was perioperative MI caused 
by early vein graft occlusion and, second, the use of 
the IMA was associated with decreased early mor- 
tality and significantly reduced the rate of overall 
unfavorable outcome vents. It appears that despite 
relatively low mortality, patients operated on with 
this technique are at increased risk of vein graft 
thrombosis.10. 13, 33 
The high rate of early graft failure has several 
explanations: it can be related to inadequate selec- 
tion of patients for this procedure (patients with 
small, calcified, or intramyocardial coronary arteries 
are not candidates for this procedure), quality of 
surgical exposure achieved, inappropriate locations 
of the anastomoses, and skill of the surgeon. How- 
ever, early graft thrombosis may also be related to 
low anticoagulation level during the procedure or to 
the fact that, unlike in bypass procedures, platelet 
function is not disturbed. 34' 35 Endothelial damage 
during the procedure may facilitate platelet aggre- 
gation with eventual graft thrombosis. The superior 
results with the use of the IMA may be related to 
luminal release of nitric oxide, which induces coro- 
nary vasodilatation and inhibits platelet adhesion 
and aggregation. 36 
Coronary anastomoses require a meticulous tech- 
nique. It appears, however, to be much more diffi- 
cult to perform perfect distal anastomoses with a 
beating heart. When a Doppler echocardiographic 
microprobe was used to measure flow through IMA 
grafts, better initial flows were observed in patients 
operated on without CPB than in those operated on 
with CPB, probably because of better unoff. 9 In the 
study cited, IMA flow in patients who underwent 
CPB gradually reached a level similar to IMA flow 
in patients operated on without CPB during the first 
postoperative week. This observation supports the 
view that a good quality of IMA anastomosis can be 
achieved, even with a beating heart. This also en- 
couraged us to use IMA grafts in patients with acute 
MI, left ventricular dysfunction, and cardiogenic 
shock. However, this notion cannot be supported 
angiographically, inasmuch as we unfortunately do 
not have routine angiographic follow-up data to 
determine the late graft patency rate in our cohort. 
Of all late unfavorable outcome events in this 
series, early return of angina was the most predom- 
inant (17 patients, 7.7%). This rate of return of 
angina within 1 year of the operation may be higher 
than that reported in the literature (5%). 5 In most 
cases angina was treated medically. However, four 
patients underwent reoperation and five underwent 
postoperative percutaneous transluminal coronary 
angioplasty. Incomplete revascularization a d tech- 
nical problems at the anastomotic sites were the 
major causes of early return of angina. 
Incomplete revascularization is an established de- 
terminant of early return of angina. 37 The relatively 
low number of grafts per patient reported in this 
study (1.9 per patient) and by other authors (1.0 to 
2.2 per patient) 6-1° is primarily related to patient 
selection. We favored the use of the CPB technique 
for patients who needed four or more grafts, al- 
though in seven patients in this cohort (3.5%) we 
performed complete revascularization with four to 
five grafts despite the technical difficulty. The sec- 
ond subpopulation that was preferably referred for 
the CPB technique included patients with disease 
involvement of the circumflex arterial system. In 
this cohort we approached this territory either 
through a midline sternotomy or left thoracotomy. 
In operations with midline sternotomy, rotation of 
the heart might not be tolerated, especially when 
severe left ventricular dysfunction with cardiomeg- 
aly is present. On the other hand, with left thora- 
cotomy, grafting of the RCA is not attainable. 
Recently, however, we used the surgical approach of 
midline sternotomy with left intercostal extension, 
which permits easier access to all coronary arterial 
territories whenever needed. 
With this technical improvement and on the basis 
of the follow-up data presented in this study, bearing 
in mind that long-term unfavorable results of incom- 
plete revascularization might take longer than a 
mean follow-up of 12 months to appear, we do not 
think that technical difficulty justifies incomplete 
revascularization. An exception to this rule is hemo- 
dynamic instability associated with severe left ven- 
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tricular dysfunction or cardiogenic shock, in which 
cases we prefer to perform only the one or two most 
important grafts, that is, those critical to patient 
survival, without CPB, although this may bear a 
higher probability of return of angina. In our expe- 
rience, in standard heart bypass technique in pa- 
tients with left ventricular dysfunction, it is of utmost 
importance to perform complete revascularization to 
minimize operative mortality. However, as this study 
indicates, relatively low operative mortality can be 
achieved in patients with severe left ventricular dys- 
function operated on without CPB, despite the lower 
number of grafts. 
We conclude that CABG without CPB can be 
done with relatively low operative mortality primar- 
ily related to vein graft thrombosis. However, the 
price may be an increased risk for early return of 
angina, mainly because of incomplete revasculariza- 
tion. Because this study is not a comparative study, 
it would not be legitimate to define indications 
for this procedure. However, we believe that this 
study provides some data concerning the esti- 
mated risk of this procedure for various subgroups 
of patients. Among several well-established risk 
factors for CABG with the use of CPB, the only 
significant independent predictors of early mor- 
tality for CABG without CPB were calcified aorta 
and emergency operation. With the reservation of 
possible type II statistical error, this study shows 
that for properly selected patients in whom the 
procedure is feasible, CABG without CPB is a 
viable alternative that should be considered when- 
ever the risk of the standard heart bypass tech- 
nique is very high and the risk of CABG without 
CPB is estimated to be lower. 
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